Sale disclosed
Donald W. DeGolyer
Director
Common Stock
- Reported value
- $126.2K
- Reported price
- $7.09 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Emergent BioSolutions Inc.
Last 30 daysNo qualifying insider buying. Sales: $145.79K by 2 insiders.
Showing the first 6 of 11 trades on this page.
Director
Common Stock
SVP, Products Business
Common Stock
SVP, Products Business
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
SVP, Products Business
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockSale10b5-1 | 17,800$7.09 / share | $126.2K | Oct 7Filed Oct 7 · 0d later | SEC filing |
| SVP, Products Business | Common StockSale10b5-1 | 3,000$6.53 / share | $19.59K | Oct 1Filed Oct 5 · 4d later | SEC filing |
| SVP, Products Business | Common StockSale10b5-1 | 3,000$8.40 / share | $25.2K | Jul 1Filed Jul 2 · 1d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 13,761avg $8.40 / share | $115.61K | May 1Filed May 4 · 3d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 15,481avg $8.40 / share | $129.99K | May 1Filed May 4 · 3d later | 2 filings
|
| Director | Common StockSale10b5-1 | 15,481$8.28 / share | $128.18K | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 17,202avg $8.40 / share | $144.45K | May 1Filed May 4 · 3d later | 2 filings
|
| SVP, Products Business | Common StockSale10b5-1 | 4,000$8.44 / share | $33.76K | Apr 1Filed Apr 3 · 2d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.